Trending News Today: FDA OKs Labeling Supplement for Neratinib in HER2-Positive Breast Cancer
Top news of the day from across the health care landscape.
The FDA has approved a labeling supplement for neratinib (Nerlynx, Puma Biotechnology) for the extended adjuvant treatment of human epidermal growth factor receptor 2-positive early stage breast cancer,
A recent study found that individuals with HIV who received kidney transplants from deceased donors with HIV achieved long-term successful outcomes from the procedure,
Walmart is rolling out a health care pilot program for its employees to connect with recommended providers based on effectiveness and cost-efficiency,
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025